ArticleCancer science2010

In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer.

Masahiro Komoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.